People first*

Diabeloop partners with patients: Since its creation, Diabeloop has been involving people living with Type 1 diabetes and their families. They have contributed to the development alongside engineers and healthcare professionals. 

The ease of use and intuitive interfaces of personalized solutions developed by Diabeloop are really inspired by patients and their personal experiences. 

The international launch of an independent young company

In November 2018, Diabeloop’s first medical device, DBLG1, was CE marked. We are working on commercializing, in Europe (France and Germany at first) and later in North America. 

To support our international ambition and our Research and Development roadmap, we completed a Series B round of funding, setting a European fundraising record for therapeutic artificial intelligence.

Reduce the heavy burden for people with diabetes

Diabeloop developed a self-learning algorithm that embeds therapeutic artificial intelligence, to automate Type 1 diabetes treatment. It is intended to relieve people affected by this chronic condition from having to make constant therapeutic decisions every day and night, and to allow them to live life without interruption.

The information magazine for healthcare professionals provides an overview of closed-loop systems for T1D treatment.

Diabeloop announces the conclusion of an agreement with exclusive distribution with Terumo Corporation for DBLG1 Automated Insulin Delivery Solution in Japanese market

https://www.asianhhm.com/pressreleases/diabeloop-sa-and-terumo-corporation-enter-into-joint-development-agreement-with-exclusive-distribution-right

Diabeloop completes a partnership with Roche

https://www.firstwordmedtech.com/node/1040814

Diabeloop appoints Catherine Dunand Chairman of the Board

https://currently.att.yahoo.com/att/diabeloop-appoints-catherine-dunand-chairman-090000439.html

Diabeloop integrates Roche's Accu-Chek insulin pump into its Automated Insulin Delivery (AID) System

https://www.mobihealthnews.com/news/roche-inks-deal-diabeloop-integrate-automated-insulin-delivery

BIOCORP, Diabeloop Partner on Automated Diabetes Management Devices

https://www.fdanews.com/articles/201976-biocorp-diabeloop-partner-on-automated-diabetes-management-devices

They talk about us

The information magazine for healthcare professionals provides an overview of closed-loop systems for T1D treatment.

Awards

French Tech 120 2020

Start Up of the Year 2019 award

InnovEIT Award 2019

Awarding fundings in 2016-2017 and 2018-2019-2020

Trophée de l'Embarqué, Health Award

Born Global Award Start-up of the Year EY 2018

Jury Prize, Start-up of the Year SNITEM

Samsung Artificial Intelligence Award Vivatech 2018